UroGen’s $58 million Initial Public Offering

Hamburger Evron & Co. represented UroGen on the transaction UroGen Pharma, which is held by Mori Arkin and the Pontifax Fund, has raised 58 million dollars…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Michael Patrini.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here